Cargando…
Anticardiac Antibodies in Patients with Chronic Pericardial Effusion
Objectives. Chronic pericardial effusion may be challenging in terms of diagnosis and treatment. Specific laboratory parameters predicting the frequency and severity of recurrences after initial drainage of pericardial effusion are lacking. Materials and Methods. Pericardial fluid (PF) and serum (SE...
Autores principales: | Karatolios, Konstantinos, Pankuweit, Sabine, Richter, Anette, Ruppert, Volker, Maisch, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749782/ https://www.ncbi.nlm.nih.gov/pubmed/26941472 http://dx.doi.org/10.1155/2016/9262741 |
Ejemplares similares
-
Cytokines in Pericardial Effusion of Patients with Inflammatory Pericardial Disease
por: Karatolios, Konstantinos, et al.
Publicado: (2012) -
Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy
por: Karatolios, Konstantinos, et al.
Publicado: (2017) -
Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy
por: Karatolios, Konstantinos, et al.
Publicado: (2018) -
Pericardial effusion of HIV-infected patients - results of a prospective multicenter cohort study in the era of antiretroviral therapy
por: Lind, A, et al.
Publicado: (2011) -
Functional Gene Module–Based Identification of Phillyrin as an Anticardiac Fibrosis Agent
por: Wang, Lei, et al.
Publicado: (2020)